Максималните плазмени концентрации на иматиниб при пациентите са 2- 4 µmol/ l.
Maximal plasma concentrations of imatinib in patients are 2– 4 µmol/ l, consequently an inhibition of CYP2D6 and/ or CYP3A4/ 5-mediated metabolism of co-administered drugs is possible.